The Role of Interleukin-10 in Women with Metastatic Invasive Ductal Carcinoma
DOI:
https://doi.org/10.32007/jfacmedbagdad.533831Keywords:
interleukin-10, metastatic invasive ductal carcinomaAbstract
Background: Breast cancer is the malignant tumor that forms from the uncontrolled growth of abnormal breast cells. It usually affects tissues involved in milk production (Ductal and lobular tissues). It is the most common malignancy in women and it remains one of the greatest health threats facing women around the world as we enter the 21st century.
Objectives: To estimate the role of IL-10 in the progression of invasive ductal carcinoma.
Patients and Method: Seventy three metastatic invasive ductal carcinoma Iraqi women were admitted to Nuclear Medicine Hospital in Baghdad and 15 samples of apparently healthy women were involved as a control. The blood samples (2 mL) were drown from all studied cases in order to be used for measuring their serum level of IL-10 by using Enzyme-linked Immune Sorbent Assay technique.
Result: The results have shown that the high significant relation was that of elevated IL-10 levels, which increased in 98.6% of patients.
Conclusion: The result indicates that the highl significant elevation of serum IL-10 concentration are strongly associated with metastatic invasive ductal carcinoma, this may be helpful in adding further vision in the diagnosis of women with this type of cancer.
Downloads
Downloads
Published
Issue
Section
License
Permit others to copy and distribute the manuscript; to extract, revise, and create another derivative
works of or from the manuscript (e.g., a translation); to incorporate the manuscript into a
collective work; and to text or data mine the article, even for commercial purposes, provided that
the author(s) is/are credited; the article's modifications should not harm the author's honor or
reputation; and the article should not be altered in a way that would cause the author to lose them
reputation. The Creative Commons Attribution 4.0 International License (CC BY 4.0) has more
information.